Natus Medical (NASDAQ:BABY) continued its restructuring, which resulted in an ugly first quarter. Fortunately, with expectations low, investors were able to shrug it off in hopes that the medical device maker will be able to come out the other side a better company.
Natus Medical results: The raw numbers
|
Metric |
Q1 2019 |
Q1 2018 |
Year-Over-Year Change |
|---|---|---|---|
|
Revenue |
$114.8 million |
$128.6 million |
(10.7%) |
|
Income from operations |
($24.2 million) |
($2.7 million) |
N/A |
|
Earnings per share (EPS) |
($0.74) |
($0.10) |
N/A |
|
Adjusted EPS |
$0.09 |
$0.24 |